Claims
- 1. A method of therapy or prophylaxis of a disease associated with reversible airways obstruction in a patient, which comprises administering to said patient an effective amount to alleviate said disease at least one compound of the formula ##STR21## or a physiologically acceptable salt or solvate thereof, wherein Q represents a 1- or 2- naphthalenyl group.
- 2. A method according to claim 1 wherein the compound comprises, 4-hydroxy-.alpha..sup.1 -[[.differential.6-[2-(2-naphthalenyl) ethoxy]hexyl]amino]methyl]-1,3-benzenedimethanol or a physiologically acceptable salt or solvate thereof.
- 3. A method according to claim 1 wherein the compound comprises 4-hydroxy-.alpha..sup.1 -[[[6-[(2-(1-naphthalenyl)ethoxy]hexyl]amino]methyl]-1,3-benzenedimethanol or a physiologically acceptable salt or solvate thereof.
- 4. A method according to claim 1, wherein the disease is asthma or chronic bronchitis.
Priority Claims (2)
Number |
Date |
Country |
Kind |
8726586 |
Nov 1987 |
GBX |
|
8821179 |
Sep 1988 |
GBX |
|
Parent Case Info
This is a continuation of co-pending application Ser. No. 07/270,945 filed Nov. 14, 1988, now U.S. Pat. No. 4,997,986.
US Referenced Citations (4)
Foreign Referenced Citations (14)
Number |
Date |
Country |
162576A |
Nov 1985 |
EPX |
223410A |
May 1987 |
EPX |
286242A |
Dec 1988 |
EPX |
2164505 |
Aug 1972 |
DEX |
95908 |
Mar 1972 |
FRX |
1069411 |
May 1967 |
GBX |
1094461 |
Dec 1967 |
GBX |
1330188 |
Sep 1973 |
GBX |
1381184 |
Jan 1975 |
GBX |
2006772 |
May 1979 |
GBX |
2140800A |
Dec 1984 |
GBX |
2159151A |
Nov 1985 |
GBX |
2165542A |
Apr 1986 |
GBX |
2182658A |
May 1987 |
GBX |
Non-Patent Literature Citations (4)
Entry |
The Merk Index, tenth Ed., 1983, pp. 573-574 (entry relating to Fenoterol). |
Coleman et al., "Novel and Versatile Superfusion System", (1989), pp. 71-86. |
Boehringer Ingelheim Limited "Berotec", ABPI Data Sheet Compendium 1988-89 p. 215. |
Fenoterol-3914 Fenoterol-p. 573. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
270945 |
Nov 1988 |
|